![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://oncoceutics.com/oncoceutics-receives-foundation-grants-to-establish-an-expanded-access-program-for-onc201/#:~:text=Philadelphia%2C%20PA%20(November%205%2C,ONC201%20in%20the%20United%20States.
https://oncoceutics.com/oncoceutics-begins-clinical-trial-with-next-generation-imipridone-onc206-at-the-nih/
https://oncoceutics.com/oncoceutics-expands-ip-portfolio-with-additional-patents-for-onc201-and-onc212/
https://oncoceutics.com/oncoceutics-to-present-additional-data-at-asco-showing-clinical-benefit-from-onc201-for-cancer-patients/
https://oncoceutics.com/phase-i-ii-clinical-study-of-onc201-begins-in-japan/